-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
-
Sabalenka books US Open quarter-final clash with Noskova
-
Noskova edges Kostyuk to reach US Open quarter-finals
-
German AfD supporters jubilant at far right's thumping win
-
Alonso urges Chelsea to learn from painful defeat at Arsenal
-
Zelensky warns war likely to continue into winter after US talks
-
Defending champion Sabalenka reaches US Open quarter-finals
-
Arsenal deliver statement fightback to end Chelsea's flying start
-
Minnows Augsburg sink Frankfurt to top Bundesliga table
-
Leclerc accepts blame as Hamilton laments Ferrari approach
-
Yamal hits double as 'nearly perfect' Barca thrash Valencia
-
Sabalenka surges past Townsend to reach US Open quarter-finals
-
Antonelli living 'a dream' after astonishing home win
-
Smiling face of Germany's far-right AfD: Ulrich Siegmund
-
Impressive Daryz keeps Arc double dream alive
-
Lebanon president calls for US help as Israeli strikes kill 7
-
Strasbourg hit Troyes for six as Amo-Ameyaw sparkles
-
Yamal hits double as perfect Barca thrash Valencia
-
German far-right AfD landslide winner in eastern state vote
-
Venice festival turns gaze on war reporters, media industry
-
Carrick defends Man Utd start despite defensive concerns
-
Sensational Antonelli wins Italian GP from back of grid
Nitches Inc. Updates Shareholders on Amazon Store Launch and Online Sales Growth for InTheZone Labs Products
Nitches Inc. (OTC PINK:NICH) is excited to announce the official placement of its first InTheZone Labs product, InTheZone Focused Extreme, on Amazon. As part of our aggressive online growth strategy, this marks a pivotal moment for the company as we expand our reach into one of the largest e-commerce platforms globally. The Amazon listing is live and available for purchase here: https://a.co/d/ggjrEED
Amazon: A Powerhouse for Nutraceuticals Growth
Amazon has established itself as a dominant sales channel for nutraceuticals and dietary supplements, with the category experiencing record growth in recent years. According to market research, the global nutraceuticals market is projected to reach $620.3 billion by 2030, driven by a surge in consumer demand for health-focused products. Nutraceutical brands on Amazon often generate millions in annual revenue, and some achieve significant success without a dedicated corporate website.
For Nitches Inc., this strategic move into Amazon provides a powerful growth vehicle. Our vision is to capitalize on Amazon's vast customer base, seamless logistics network, and trusted marketplace reputation. This represents a major milestone in our plan to scale InTheZone Labs into a globally recognized brand.
InTheZone Labs Products: Meeting Consumer Demand for Science-Backed Wellness
Our Amazon store launch begins with InTheZone Focused Extreme, the flagship nootropic and nutraceutical supplement designed to boost mental clarity, cognitive support, and sustained energy. This premium formulation includes bioceutical-grade ingredients such as Alpha-GPC, Lion's Mane Mushroom, and Omega-3 DHA, all designed to help users unlock their full potential.
In the coming weeks, we plan to expand the Amazon catalog with two additional products:
1. InTheZone Focused Youth: A cognitive support supplement tailored for younger users seeking sharper focus and mental stamina, enriched with brain-boosting ingredients like Phosphatidylserine and Bacopa Monnieri.
2. InTheZone Passion: A vitality-enhancing supplement for men that supports hormonal balance, libido, and energy levels, featuring clinically backed ingredients such as Tribulus Terrestris and Fenugreek.
Each product is crafted in FDA-compliant, GMP-certified facilities in the United States, reflecting our commitment to quality, safety, and transparency.
Next Steps and Exciting Developments
Our team is actively working with Amazon to enhance product pages, optimize listings, and integrate advanced marketing campaigns. Next week, we plan to announce an exciting development that will further accelerate the growth of InTheZone Labs' online sales and brand visibility.
Why This Matters for Shareholders
Nitches' online rapid growth strategy is showing tangible results. As we expand the InTheZone Labs presence on Amazon, we are tapping into a proven revenue channel. Many nutraceutical brands have built multi-million-dollar businesses solely through Amazon's marketplace, leveraging its vast audience and streamlined logistics to scale rapidly.
The nutraceuticals and nootropics categories are experiencing unprecedented demand as consumers increasingly prioritize health, wellness, and cognitive enhancement. InTheZone Labs is well-positioned to capture market share with its science-backed, American-made products. Our commitment to constant updates, high-quality formulations, and strategic partnerships underscores our long-term vision of growth and profitability.
FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
For additional updates, shareholders are encouraged to follow our progress at www.inthezonelabs.com
For media inquiries, please contact:
John Morgan
Public Relations Lead
Nitches Inc.
Nitches Inc. remains committed to driving shareholder value through strategic innovation, expanding our market footprint, and building brands that make an impact.
Contact Information
John Morgan
Ceo
[email protected]
SOURCE: Nitches, Inc.
W.Moreno--AT